Sign in

CIK 0001401040

  • Non-accelerated filer
  • Smaller reporting company

DiaMedica Therapeutics Inc.

Sign in to watch
Ticker
DMAC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Canada (Federal Level)
Entity type
Operating
Phone
+1 763-496-5454
Business address
301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
Former names
DiaMedica Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-05-24 Kellen Scott CFO and Secretary Purchase +4,000 $2.94 $12K 7,290
2019-03-27 ALCORN HARRY W JR Chief Medical Officer Purchase +150 $4.46 $668 1,150
2018-12-11 Xiao Zhenyu Director Purchase +3,250 $4.00 $13K 7,100
2018-12-11 Verdoorn Todd A. Chief Scientific Officer Purchase +1,000 $4.00 $4K 2,000
2018-12-11 Pilnik Richard D. Director Purchase +6,250 $4.00 $25K 23,838
2018-12-11 Pauls Dietrich John President and CEO Purchase +5,000 $4.00 $20K 29,804
2018-12-11 Parsons James T. Director Purchase +2,250 $4.00 $9K 6,100
2018-12-11 Kellen Scott CFO and Secretary Purchase +1,250 $4.00 $5K 3,290
2018-12-11 Giuffre Randall Michael Director Purchase +11,250 $4.00 $45K 85,804
2018-12-11 ALCORN HARRY W JR Chief Medical Officer Purchase +1,000 $4.00 $4K 1,000

Page 4 of 4 · 70 trades